FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marco Valgimigli

Research Profile

Procedures

Devices

Disorders

Concepts & Ideas

Chemicals & Drugs

Anatomy

Coronary Vessels

Co-author Network

Publications

TOP 3
Marco Valgimigli; Corrado Vassanelli; Leonardo Bolognese; Gianluca Campo; Salvatore Colangelo; Nicoletta de Cesare; José F Díaz Fernández; Roberto Ferrari; Stefania Gambetti; Raul Moreno; Marco Stefano Nazzaro; Giovanni Parrinello; Carlo Penzo; Tommaso Piva; Francesco Prati; Flavio Ribichini; Alfredo E Rodriguez; Filippo Russo; Imad Sheiban
Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY).
Marco Valgimigli; Pascal Vranckx; Marco Borghesi; Roberto Ferrari; Giovanni Parrinello; Matteo Tebaldi
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY).
Alaide Chieffo; Flavio Airoldi; Chourmouzios Arampatzis; Christophe Caussin; Andrejs Erglis; Stefano Galli; Mika Laine; Azeem Latib; Philip Maccarthy; Fina Mauri; Alberto Menozzi; Ghada Mikhail; Ramon Lopez Palop; Patrizia Presbitero; Bernhard Reimers; Francesco Romeo; Manuel Sabate; Marco Valgimigli; Ferdinando Varbella; Antonio Colombo
A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marco Valgimigli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marco Valgimigli; Corrado Vassanelli; Leonardo Bolognese; Gianluca Campo; Salvatore Colangelo; Nicoletta de Cesare; José F Díaz Fernández; Roberto Ferrari; Stefania Gambetti; Raul Moreno; Marco Stefano Nazzaro; Giovanni Parrinello; Carlo Penzo; Tommaso Piva; Francesco Prati; Flavio Ribichini; Alfredo E Rodriguez; Filippo Russo; Imad Sheiban
Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY).
International journal of cardiology 2013;165(1):134-41.
2013: Marco Valgimigli; Pascal Vranckx; Marco Borghesi; Roberto Ferrari; Giovanni Parrinello; Matteo Tebaldi
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY).
European heart journal 2013;34(12):909-19.
2013: Alaide Chieffo; Flavio Airoldi; Chourmouzios Arampatzis; Christophe Caussin; Andrejs Erglis; Stefano Galli; Mika Laine; Azeem Latib; Philip Maccarthy; Fina Mauri; Alberto Menozzi; Ghada Mikhail; Ramon Lopez Palop; Patrizia Presbitero; Bernhard Reimers; Francesco Romeo; Manuel Sabate; Marco Valgimigli; Ferdinando Varbella; Antonio Colombo
A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial.
American heart journal 2013;165(1):65-72.
2013: S Biscaglia; Gianluca Campo; M Tebaldi; P Vranckx; Marco Valgimigli
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention.
Journal of thrombosis and haemostasis : JTH 2013;11(1):192-4.
2012: Vasim Farooq; Hector Garcia-Garcia; Arie Pieter Kappetein; Marie Angèle Morel; Lorenz Räber; Ewout W Steyerberg; Michael Swart; Marco Valgimigli; Yvonne Vergouwe; Pascal Vranckx; Stephan Windecker; Keith D Dawkins; Ton de Vries; Roberto Diletti; Patrick Washington Serruys
Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score.
European heart journal 2012;33(24):3098-104.
2012: Manel Sabate; Antonio Serra; Antonio Silvestro; Matteo Tebaldi; Maurizio Tespili; Marco Valgimigli; Gerrit-Anne van Es; Robert Jan Van geuns; Nicolás Vazquez; Fernando Alfonso; Bianca Backx; José Antonio Baz; Armando Bethencourt; Pascual Bordes; Salvatore Brugaletta; Angel Cequier; Pieter den Heijer; Joan Antoni Gómez-Hospital; Rosana Hernandez-Antolin; Andrés Iñiguez; Vicente Mainar; Victoria Martin-Yuste; Mónica Masotti; Patrick Washington Serruys
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial.
Lancet 2012;380(9852):1482-90.
2012: Marco Valgimigli; Sergio Leonardi
Peri-procedural myocardial infarction and troponism: a quick journey through the land of confusion.
Heart (British Cardiac Society) 2012;98(19):1400-1.
2012: Alaide Chieffo; Arvind Agnihotri; Ottavio Alfieri; Pawel E Buszman; Davide Capodanno; Piera Capranzano; Tarun Chakravarty; Andrejs Erglis; Jean Fajadet; Sanda Jegere; Young-Hak Kim; Azeem Latib; Thierry Lefevre; Martin B Leon; Raj R Makkar; Ronan Margey; Sebastiano Marra; Roxana Mehran; Emanuele Meliga; Marie-Claude Morice; Jeffrey W Moses; Christoph Naber; Yoshinobu Onuma; Igor F Palacios; Seung-Jung Park; Patrick Washington Serruys; Imad Sheiban; Corrado Tamburino; Marco Valgimigli; Antonio Colombo
Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
JACC. Cardiovascular interventions 2012;5(7):718-27.
2012: Pascal Vranckx; Maurizio Anselmi; Giuseppe Biondi-Zoccai; Leonardo Bolognese; Gianluca Campo; Salvatore Colangelo; José F Díaz Fernández; Luca Favero; Roberto Ferrari; Raul Moreno; Marco Stefano Nazzaro; Tommaso Piva; Francesco Prati; Marco Valgimigli
Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2012;8(1):71-8.
2012: Marco Valgimigli; Pascal Vranckx; Marco Borghesi; Gianluca Campo; Elisa Cangiano; Fausto Castriota; Caterina Cavazza; Federico Colombo; Roberto Ferrari; Alice Frangione; Giuseppe Fucà; Moh'd Kubbajeh; Jlenia Marchesini; Monica Minarelli; Monia Monti; Giovanni Parrinello; Gianfranco Percoco; Antonella Scalone; Matteo Tebaldi; Carlo Tumscitz
Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial.
Circulation 2012;125(16):2015-26.
2012: Marco Valgimigli; Laura Bristot; Gianluca Campo; Roberto Ferrari; Stefania Gambetti; Monia Monti; Giovanni Parrinello; Matteo Tebaldi
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial.
JACC. Cardiovascular interventions 2012;5(3):268-77.
2011: Pascal Vranckx; Marco Valgimigli; Gerrit-Anne van Es; Eric Boersma; Scot Garg; Dick M Goedhart; Patrick Washington Serruys
Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2011;7(7):859-71.
2011: Gianluca Campo; Paolo Ferraresi; Jlenia Marchesini; francesco bernardi; Marco Valgimigli
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention.
Journal of thrombosis and haemostasis : JTH 2011;9(10):2106-8.
2011: Giuseppe Biondi-Zoccai; Fiorenzo Gaita; Marzia Lotrionte; Enrico Romagnoli; Giuseppe Sangiorgi; Antonio Abbate; Pierfrancesco Agostoni; Dominick J Angiolillo; Luca Testa; Marco Valgimigli; Imad Sheiban
Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes.
International journal of cardiology 2011;150(3):325-31.
2011: Marco Valgimigli
AMI on the move.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2011;7(4):415, 417, 419.
2011: Elisa Cangiano; Caterina Cavazza; Gianluca Campo; Gloria Francolini; Patrizia Malagutti; Claudio Pratola; Marco Valgimigli; Roberto Ferrari
Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease.
Journal of thrombosis and thrombolysis 2011;32(1):1-8.
2011: Scot Garg; Chrysafios Girasis; Lorenz Räber; Giovanna Sarno; Marco Bressers; Gianluca Campo; Keith D Dawkins; Ton de Vries; Hector M. Garcia; Michael Swart; Marco Valgimigli; Gerrit-Anne van Es; Pascal Vranckx; Stephan Windecker; Patrick Washington Serruys
A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials.
JACC. Cardiovascular interventions 2011;4(6):645-53.
2011: Pascal Vranckx; Marco Valgimigli; Patrick Serruys
Looking back into the future: desirudin in acute coronary syndromes and coronary stenting.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2011;7(2):263-9.
2011: Scot Garg; Giovanna Sarno; Patrick Washington Serruys; Alfredo E Rodriguez; Leonardo Bolognese; Maurizio Anselmi; Nicoletta De Cesare; Salvatore Colangelo; Raul Moreno; Stefania Gambetti; Monia Monti; Laura Bristot; Marco Bressers; Hector M. Garcia; Giovanni Parrinello; Gianluca Campo; Marco Valgimigli
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
JACC. Cardiovascular interventions 2011;4(1):66-75.
2011: Marco Valgimigli; Gianluca Campo; Patrizia Malagutti; Maurizio Anselmi; Leonardo Bolognese; Flavio Ribichini; Giacomo Boccuzzi; Nicoletta de Cesare; Alfredo E Rodriguez; Filippo Russo; Raul Moreno; Giuseppe Biondi-Zoccai; Carlo Penzo; José F Díaz Fernández; Giovanni Parrinello; Roberto Ferrari
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
JACC. Cardiovascular interventions 2011;4(1):51-62.
2010: Marco Valgimigli; Gianluca Campo; Gianfranco Percoco; Monia Monti; Fabrizio Ferrari; Carlo Tumscitz; Andrea Zuffi; Federico Colombo; Moh'd Kubbajeh; Caterina Cavazza; Elisa Cangiano; Matteo Tebaldi; Monica Minarelli; Chiara Arcozzi; Antonella Scalone; Alice Frangione; Marco Borghesi; Jlenia Marchesini; Giovanni Parrinello; Roberto Ferrari
Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY).
American heart journal 2010;160(5):804-11.
2010: Gianluca Campo; Luca Fileti; Marco Valgimigli; Matteo Tebaldi; Elisa Cangiano; Caterina Cavazza; Jlenia Marchesini; Roberto Ferrari
Poor response to clopidogrel: current and future options for its management.
Journal of thrombosis and thrombolysis 2010;30(3):319-31.
2010: Gianluca Campo; Marco Valgimigli; Chiara Carrescia; Roberto Carletti; Roberto Ferrari
Tailored medical and interventional therapy against recurrent stent thrombosis after drug-eluting stenting.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2010;16(5):591-3.
2010: Marco Valgimigli; Gianluca Campo; M Tebaldi; M Monti; S Gambetti; A Scalone; G Parrinello; Roberto Ferrari
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting.
Journal of thrombosis and haemostasis : JTH 2010;8(9):1903-11.
2010: Yoshinobu Onuma; Chrysafios Girasis; Nicolo Piazza; Hector M. Garcia; Neville Kukreja; Scot Garg; Jannet Eindhoven; Jin-Ming Cheng; Marco Valgimigli; Ron van Domburg; Patrick Washington Serruys
Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
JACC. Cardiovascular interventions 2010;3(6):584-94.
2010: Azeem Latib; Luca Ferri; Alfonso Ielasi; John Cosgrave; Cosmo Godino; Erminio Bonizzoni; Enrico Romagnoli; Alaide Chieffo; Marco Valgimigli; Carlo Penzo; Mauro Carlino; Iassen Michev; Giuseppe M Sangiorgi; Matteo Montorfano; Flavio Airoldi; Antonio Colombo
Comparison of the long-term safety and efficacy of drug-eluting and bare-metal stent implantation in saphenous vein grafts.
Circulation. Cardiovascular interventions 2010;3(3):249-56.
2010: Alban Dibra; Klaus Tiroch; Stefanie Schulz; Henning Kelbaek; Christian Spaulding; Gert-Jan Laarman; Marco Valgimigli; Emilio Di Lorenzo; Christoph Kaiser; Ilkka Tierala; Julinda Mehilli; Gianluca Campo; Leif Thuesen; Maarten A Vink; Martin J Schalij; ROBERTO VIOLINI; Albert Schömig; Adnan Kastrati
Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials.
Clinical research in cardiology : official journal of the German Cardiac Society 2010;99(6):345-57.
2010: Gianluca Campo; Luca Fileti; Jlenia Marchesini; Antonella Scalone; Marco Valgimigli; Roberto Ferrari
Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban.
Journal of blood medicine 2010;1():61-9.
2009: Matteo Tebaldi; Chiara Arcozzi; Gianluca Campo; Gianfranco Percoco; Roberto Ferrari; Marco Valgimigli
The 5-year clinical outcomes after a randomized comparison of sirolimus-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2009;54(20):1900-1.
2009: Marco Valgimigli; Flavio Airoldi; Marco Zimarino
Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?
Journal of cardiovascular medicine (Hagerstown, Md.) 2009;10 Suppl 1():S17-26.
2009: Emanuele Meliga; Hector M. Garcia; Marco Valgimigli; Alaide Chieffo; Giuseppe G L Biondi-Zoccai; Andrew O Maree; N Gonzalo; S Cook; S Marra; Claudio Moretti; Stefano De Servi; Igor F Palacios; Stephan Windecker; Ron T van Domburg; Antonio Colombo; Imad Sheiban; Patrick Washington Serruys
Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT).
International journal of cardiology 2009;137(1):16-21.
2009: Pascal Vranckx; Carl Schultz; Marco Valgimigli; Janette A Eindhoven; Arie Pieter Kappetein; Evelyn Regar; Ron Van Domburg; Patrick Washington Serruys
Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;74(2):302-10.
2009: Giuseppe De Luca; Marco Valgimigli; Christian Spaulding; Maurizio Menichelli; Hans Peter Brunner-La Rocca; Bas L van der Hoeven; Emilio Di Lorenzo; Luis-S Diaz de la Llera; Vincenzo Pasceri; Undine Pittl; Gianfranco Percoco; ROBERTO VIOLINI; Gregg W Stone
Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
Journal of thrombosis and thrombolysis 2009;28(2):200-10.
2009: G Campo; Marco Valgimigli; R Carletti; L Fileti; R Ferrari
Long-term outcome after percutaneous coronary intervention in patients with essential thrombocythemia.
Journal of thrombosis and haemostasis : JTH 2009;7(7):1235-8.
2009: Giampaolo Niccoli; D'Amario Domenico; Cristina Spaziani; Nicola Cosentino; Marcello Marino; Stefano Rigattieri; Paolo Lo Schiavo; Maria De Vita; Fabio Tarantino; Antonio Bartorelli; Franco Fabbiocchi; Francesco Prati; Fabrizio Imola; Marco Valgimigli; Roberto Ferrari; Filippo Crea
Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
Journal of cardiovascular medicine (Hagerstown, Md.) 2009;10(7):585-92.
2009: Marco Valgimigli; Gianluca Campo; Nicoletta de Cesare; Emanuele Meliga; Pascal Vranckx; Alessandro Furgieri; Dominick J Angiolillo; Manel Sabatè; Martial Hamon; Alessandra Repetto; Salvatore Colangelo; Salvatore Brugaletta; Giovanni Parrinello; Gianfranco Percoco; Roberto Ferrari
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
Circulation 2009;119(25):3215-22.
2009: Piera Angelica Merlini; Marco Valgimigli
[The FATA study].
Giornale italiano di cardiologia (2006) 2009;10(6):358-63.
2009: Giuseppe De Luca; Gregg W Stone; Harry Suryapranata; Gert-Jan Laarman; Maurizio Menichelli; Christoph Kaiser; Marco Valgimigli; Emilio Di Lorenzo; Maurits T Dirksen; Christian Spaulding; Undine Pittl; ROBERTO VIOLINI; Gianfranco Percoco; Paolo Marino
Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
International journal of cardiology 2009;133(2):213-22.
2009: Raisuke Iijima; Robert A Byrne; Alban Dibra; Gjin Ndrepepa; Christian Spaulding; Gert-Jan Laarman; Maurizio Menichelli; Marco Valgimigli; Emilio Di Lorenzo; Christoph Kaiser; Ilkka Tierala; Julinda Mehilli; Maarten J Suttorp; ROBERTO VIOLINI; Albert Schömig; Adnan Kastrati
Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials.
Revista española de cardiología 2009;62(4):354-64.
2009: Antonio Maria Leone; Marco Valgimigli; Maria Benedetta Giannico; Vincenzo Zaccone; Matteo Perfetti; D'Amario Domenico; Antonio G Rebuzzi; Filippo Crea
From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells.
European heart journal 2009;30(8):890-9.
2009: Paolo Ferraresi; Gianluca Campo; Giovanna Marchetti; Mirko Pinotti; Marco Valgimigli; Donato Gemmati; Roberto Ferrari; francesco bernardi
Temporal and genotype-driven variation of factor VII levels in patients with acute myocardial infarction.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15(1):119-22.
2009: Arnoud W J van 't Hof; Marco Valgimigli
Defining the role of platelet glycoprotein receptor inhibitors in STEMI: focus on tirofiban.
Drugs 2009;69(1):85-100.
2008: G Campo; Marco Valgimigli; A Frangione; M Tebaldi; R Ferrari
Prognostic value of serial platelet reactivity measurements on long-term clinical outcome in patients with ST-elevation myocardial infarction undergoing primary PCI.
Journal of thrombosis and haemostasis : JTH 2008;6(10):1824-6.
2008: Paul Steendijk; E Meliga; Marco Valgimigli; F J Ten Cate; Patrick Washington Serruys
Acute effects of alcohol septal ablation on systolic and diastolic left ventricular function in patients with hypertrophic obstructive cardiomyopathy.
Heart (British Cardiac Society) 2008;94(10):1318-22.
2008: Giuseppe G L Biondi-Zoccai; Marco Valgimigli; Imad Sheiban; Massimo Margheri; Antonio Marzocchi; Francesco Prati; Massimo Vischi; Corrado Lettieri; ROBERTO VIOLINI; Gennaro Sardella; Amerigo Stabile; Fabrizio Clementi; Francesco Romeo; Antonio Colombo; Giuseppe Sangiorgi
A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.
Journal of cardiovascular medicine (Hagerstown, Md.) 2008;9(9):957-62.
2008: Alaide Chieffo; Seung-Jung Park; Emanuele Meliga; Imad Sheiban; Michael S Lee; Azeem Latib; Young-Hak Kim; Marco Valgimigli; Dario Sillano; Valeria Magni; Giuseppe G L Biondi-Zoccai; Matteo Montorfano; Flavio Airoldi; Renata Rogacka; Mauro Carlino; Iassen Michev; Cheol Whan Lee; Myeong-Ki Hong; Seong-Wook Park; Claudio Moretti; Erminio Bonizzoni; Giuseppe M Sangiorgi; Jonathan Tobis; Patrick Washington Serruys; Antonio Colombo
Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry.
European heart journal 2008;29(17):2108-15.
2008: Emanuele Meliga; Marco Valgimigli; Pawel Buszman; Patrick Washington Serruys
Percutaneous coronary intervention or coronary artery bypass graft for unprotected left main coronary artery disease: the endless debate.
Journal of the American College of Cardiology 2008;52(7):582-4; author reply 584-6.
2008: Alberto Cremonesi; Carlo Setacci; Fausto Castriota; Marco Valgimigli
Carotid stent cell design: lack of benefit or lack of evidence?
Stroke; a journal of cerebral circulation 2008;39(8):e130; author reply e133.
2008: Marco Valgimigli; Gianluca Campo; Nicoletta de Cesare; Pascal Vranckx; Martial Hamon; Dominick J Angiolillo; Manel Sabatè; Fabrizio Ferrari; Alessandro Furgieri; Carlo Tumscitz; Alessandra Repetto; Salvatore Colangelo; Emanuele Meliga; Moh'd Kubbajeh; Giovanni Parrinello; Gianfranco Percoco; Roberto Ferrari
Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol design.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2008;22(4):313-20.
2008: Marco Valgimigli; Nicole Mittmann; David J Cohen; Gianluca Campo; Pierre K Isogai; Soo Jin Seung; Brian Dulisse; Chiara Arcozzi; Paolo Squasi; Gianfranco Percoco; Roberto Ferrari
A strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction.
International journal of cardiology 2008;128(1):53-61.
2008: Emanuele Meliga; Hector M. Garcia; Marco Valgimigli; Alaide Chieffo; Giuseppe G L Biondi-Zoccai; Andrew O Maree; Stephen Cook; Lindsay Reardon; Claudio Moretti; Stefano De Servi; Igor F Palacios; Stephan Windecker; Antonio Colombo; Ron T van Domburg; Imad Sheiban; Patrick Washington Serruys
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
Journal of the American College of Cardiology 2008;51(23):2212-9.
2008: Marcello Galvani; Maria De Vita; Marco Valgimigli
[The ACUITY trial: one-year results].
Giornale italiano di cardiologia (2006) 2008;9(6):377-83.
2008: Emanuele Meliga; Hector M. Garcia; Marco Valgimigli; Alaide Chieffo; Giuseppe Biondi-Zoccai; Andrew O Maree; Nieves Gonzalo; Stephane Cook; Ignacio Cruz-Gonzalez; Sebastiano Marra; Stefano De Servi; Igor F Palacios; Stephan Windecker; Ron van Domburg; Antonio Colombo; Imad Sheiban; Patrick Washington Serruys
Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The diabetes and drug eluting stent for LeFT main registry (D-DELFT).
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2008;4(1):77-83.
2008: Hüseyin Ince; Marco Valgimigli; Michael Petzsch; J Suarez de Lezo; F Kuethe; Simone Dunkelmann; G Biondi-Zoccai; Christoph A Nienaber
Cardiovascular events and re-stenosis following administration of G-CSF in acute myocardial infarction: systematic review and meta-analysis.
Heart (British Cardiac Society) 2008;94(5):610-6.
2008: Marco Valgimigli; Gianluca Campo; Gianfranco Percoco; Leonardo Bolognese; Corrado Vassanelli; Salvatore Colangelo; Nicoletta de Cesare; Alfredo E Rodriguez; Maurizio Ferrario; Raul Moreno; Tommaso Piva; Imad Sheiban; Giampaolo Pasquetto; Francesco Prati; Marco Stefano Nazzaro; Giovanni Parrinello; Roberto Ferrari
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.
JAMA : the journal of the American Medical Association 2008;299(15):1788-99.
2008: Dietlind Zohlnhöfer; Alban Dibra; Tobias Koppara; Antoinette de Waha; Rasmus Sejersten Ripa; Jens Kastrup; Marco Valgimigli; Albert Schömig; Adnan Kastrati
Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis.
Journal of the American College of Cardiology 2008;51(15):1429-37.
2008: Emanuele Meliga; Paul Steendijk; Marco Valgimigli; Folkert J Ten Cate; Patrick Washington Serruys
Effects of percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy on systolic and diastolic left ventricular function assessed by pressure-volume loops.
The American journal of cardiology 2008;101(8):1179-84.
2008: Marco Valgimigli; Gianluca Campo; Matteo Tebaldi; Roberto Carletti; Chiara Arcozzi; Roberto Ferrari; Gianfranco Percoco
Abciximab: a reappraisal of its use in coronary care.
Biologics : targets & therapy 2008;2(1):29-39.
2008: Giuseppe G L Biondi-Zoccai; Marzia Lotrionte; Claudio Moretti; Emanuele Meliga; Pierfrancesco Agostoni; Marco Valgimigli; Angela Migliorini; David Antoniucci; Didier Carrié; Giuseppe Sangiorgi; Alaide Chieffo; Antonio Colombo; Matthew J Price; Paul S Teirstein; Evald H Christiansen; Antonio Abbate; Luca Testa; Julian P G Gunn; Francesco Burzotta; Antonio Laudito; Gian Paolo Trevi; Imad Sheiban
A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease.
American heart journal 2008;155(2):274-83.
2007: Adnan Kastrati; Alban Dibra; Christian Spaulding; Gert-Jan Laarman; Maurizio Menichelli; Marco Valgimigli; Emilio Di Lorenzo; Christoph Kaiser; Ilkka Tierala; Julinda Mehilli; Melchior Seyfarth; Olivier Varenne; Maurits T Dirksen; Gianfranco Percoco; Attilio Varricchio; Undine Pittl; Mikko Syvänne; Maarten J Suttorp; ROBERTO VIOLINI; Albert Schömig
Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.
European heart journal 2007;28(22):2706-13.
2007: Marzia Lotrionte; Giuseppe G L Biondi-Zoccai; Pierfrancesco Agostoni; Antonio Abbate; Dominick J Angiolillo; Marco Valgimigli; Claudio Moretti; Emanuele Meliga; Thomas Cuisset; Marie-Christine Alessi; Gilles Montalescot; Jean-Philippe Collet; Germano Di Sciascio; Ron Waksman; Luca Testa; Giuseppe Sangiorgi; Antonio Laudito; Gian Paolo Trevi; Imad Sheiban
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.
The American journal of cardiology 2007;100(8):1199-206.
2007: Gaston A. Rodriguez-Granillo; Sebastiaan De Winter; Nico Bruining; Jurgen M R Ligthart; Héctor M García-García; Marco Valgimigli; Pim J de Feyter
Effect of perindopril on coronary remodelling: insights from a multicentre, randomized study.
European heart journal 2007;28(19):2326-31.
2007: Gianluca Campo; Marco Valgimigli; Donato Gemmati; Gianfranco Percoco; Linda Catozzi; Alice Frangione; Federica Federici; Fabrizio Ferrari; Matteo Tebaldi; Serena Luccarelli; Giovanni Parrinello; Roberto Ferrari
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study.
Journal of the American College of Cardiology 2007;50(12):1132-7.
2007: Marco Valgimigli; Patrizia Malagutti
The heart of coronary arteries.
European heart journal 2007;28(17):2063.
2007: Marco Valgimigli; Gianluca Campo; Chiara Arcozzi; Patrizia Malagutti; Roberto Carletti; Fabrizio Ferrari; Dario Barbieri; Giovanni Parrinello; Gianfranco Percoco; Roberto Ferrari
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study.
Journal of the American College of Cardiology 2007;50(2):138-45.
2007: Alaide Chieffo; Seung J Park; Marco Valgimigli; Young H Kim; Joost Daemen; Imad Sheiban; Alessandra Truffa; Matteo Montorfano; Flavio Airoldi; Giuseppe Sangiorgi; Mauro Carlino; Iassen Michev; Cheol W Lee; Myeong K Hong; Seong W Park; Claudio Moretti; Erminio Bonizzoni; Renata Rogacka; Patrick Washington Serruys; Antonio Colombo
Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry.
Circulation 2007;116(2):158-62.
2007: Marco Valgimigli; Leonardo Bolognese; Maurizio Anselmi; Gianluca Campo; Alfredo E Rodriguez; Nicoletta de Cesare; David J Cohen; Imad Sheiban; Salvatore Colangelo; Giampaolo Pasquetto; Martial Hamon; Pascal Vranckx; Maurizio Ferrario; Francesco Prati; Pierfrancesco Agostoni; Patrizia Malagutti; Chiara Arcozzi; Giovanni Parrinello; Corrado Vassanelli; Roberto Ferrari; Gianfranco Percoco
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial.
American heart journal 2007;154(1):39-45.
2007: Marco Valgimigli; Patrick Washington Serruys; Keiichi Tsuchida; Sophia Vaina; Marie-angèle Morel; M J B M van den Brand; Antonio Colombo; Marie-Claude Morice; Keith D Dawkins; Bernard De Bruyne; Ran Kornowski; Stefano De Servi; Giulio Guagliumi; J Wouter Jukema; Friedrich-Wilhelm Mohr; Arie Pieter Kappetein; Kristel Wittebols; Hans-Peter Stoll; eric boersma; Giovanni Parrinello
Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention.
The American journal of cardiology 2007;99(8):1072-81.
2007: Marco Valgimigli; Pierfrancesco Agostoni; Patrick Washington Serruys
Acute coronary syndromes: an emphasis shift from treatment to prevention; and the enduring challenge of vulnerable plaque detection in the cardiac catheterization laboratory.
Journal of cardiovascular medicine (Hagerstown, Md.) 2007;8(4):221-9.
2007: Giuseppe G L Biondi-Zoccai; Marzia Lotrionte; Pierfrancesco Agostoni; Marco Valgimigli; Antonio Abbate; Giuseppe Sangiorgi; Claudio Moretti; Imad Sheiban
Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: evidence from a meta-regression.
American heart journal 2007;153(4):587-93.
2007: Adnan Kastrati; Julinda Mehilli; Jürgen Pache; Christoph Kaiser; Marco Valgimigli; Henning Kelbaek; Maurizio Menichelli; Manel Sabaté; Maarten J Suttorp; Dietrich Baumgart; Melchior Seyfarth; Matthias E Pfisterer; Albert Schömig
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.
The New England journal of medicine 2007;356(10):1030-9.
2007: Marco Valgimigli; Giuseppe G L Biondi-Zoccai; Pierfrancesco Agostoni
Clinical implications of the PROTECT-TIMI-30 trial.
Journal of the American College of Cardiology 2007;49(6):729-30; author reply 730-1.
2007: Patrizia Malagutti; Jurgen M R Ligthart; Filippo Cademartiri; Willem B Meijboom; Marco Valgimigli
Plaque sealing: are the benefits outweighing the risks?
International journal of cardiology 2007;115(2):265-6.
2007: Marco Valgimigli; Alaide Chieffo; Thierry Lefèvre; Antonio Colombo; Marie-Claude Morice; Patrick Washington Serruys
Revisiting the incidence and temporal distribution of cardiac and sudden death in patients undergoing elective intervention for unprotected left main coronary artery stenosis in the drug eluting stent era.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2007;2(4):435-43.
2007: Giuseppe G L Biondi-Zoccai; Antonio Abbate; Marco Valgimigli; Pierfrancesco Agostoni
Keeping a high standard in quantitative analyses, meta-analyses, and systematic reviews.
European heart journal 2007;28(4):516-7; author reply 517-8.
2007: Marco Valgimigli; Keith D Dawkins; Carlos Macaya; Bernard De Bruyne; Emmanuel Teiger; Jean Fajadet; Richardt Gert; Stefano De Servi; Angelo Ramondo; Kristel Wittebols; Hans-Peter Stoll; Tessa Rademaker-Havinga; Patrick Washington Serruys
Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trial.
Journal of the American College of Cardiology 2007;49(4):431-41.
2007: Marco Valgimigli; Gaston A. Rodriguez-Granillo; Hector M. Garcia; Sophia Vaina; Peter P T de Jaegere; Pim de Feyter; Patrick Washington Serruys
Plaque composition in the left main stem mimics the distal but not the proximal tract of the left coronary artery: influence of clinical presentation, length of the left main trunk, lipid profile, and systemic levels of C-reactive protein.
Journal of the American College of Cardiology 2007;49(1):23-31.
2007: Giuseppe G L Biondi-Zoccai; Marzia Lotrionte; Antonio Abbate; Marco Valgimigli; Luca Testa; Francesco Burzotta; Filippo Crea; Pierfrancesco Agostoni
Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patients.
International journal of cardiology 2007;114(1):104-5.
2007: Donato Gemmati; Federica Federici; Gianluca Campo; Silvia Tognazzo; Maria L Serino; Monica De Mattei; Marco Valgimigli; Patrizia Malagutti; Gabriele Guardigli; Paolo Ferraresi; francesco bernardi; Roberto Ferrari; Gian L Scapoli; Linda Catozzi
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients.
Molecular medicine (Cambridge, Mass.) 2007;13(1-2):112-20.
2006: Marco Valgimigli; Gianfranco Percoco; Leonardo Bolognese
Drug-eluting stents in primary PCI.
The New England journal of medicine 2006;355(23):2484; author reply 2484-6.
2006: Gianluca Campo; Marco Valgimigli; Donato Gemmati; Gianfranco Percoco; Silvia Tognazzo; Giordano Cicchitelli; Linda Catozzi; Patrizia Malagutti; Maurizio Anselmi; Corrado Vassanelli; Gian L Scapoli; Roberto Ferrari
Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study.
Journal of the American College of Cardiology 2006;48(11):2178-85.
2006: Gianluca Campo; Marco Valgimigli; Paolo Ferraresi; Patrizia Malagutti; Marcello Baroni; Chiara Arcozzi; Donato Gemmati; Gianfranco Percoco; Giovanni Parrinello; Roberto Ferrari; francesco bernardi
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(12):2800-6.
2006: Martial Hamon; Giuseppe G L Biondi-Zoccai; Patrizia Malagutti; Pierfrancesco Agostoni; Rémy Morello; Marco Valgimigli; Martial Hamon
Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis.
Journal of the American College of Cardiology 2006;48(9):1896-910.
2006: Marco Valgimigli; Patrizia Malagutti; Gaston A. Rodriguez-Granillo; Keiichi Tsuchida; Hector M. Garcia; Carlos A G Van Mieghem; Willem J van der Giessen; Pim de Feyter; Peter P T de Jaegere; Ron T van Domburg; Patrick Washington Serruys
Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries.
American heart journal 2006;152(5):896-902.
2006: Gaston A. Rodriguez-Granillo; Sophia Vaina; Héctor M García-García; Marco Valgimigli; Eric Duckers; Robert Jan Van geuns; Evelyn Regar; Willem J van der Giessen; Marco Bressers; Dick M Goedhart; Marie-angèle Morel; Pim J de Feyter; Patrick Washington Serruys
Reproducibility of intravascular ultrasound radiofrequency data analysis: implications for the design of longitudinal studies.
The international journal of cardiovascular imaging 2006;22(5):621-31.
2006: Elena Biagini; Marco Valgimigli; Pieter C Smits; Don Poldermans; Arend F L Schinkel; Vittoria Rizzello; Emile E M Onderwater-; Manolis Bountioukos; Patrick Washington Serruys
Stress and tissue Doppler echocardiographic evidence of effectiveness of myoblast transplantation in patients with ischaemic heart failure.
European journal of heart failure 2006;8(6):641-8.
2006: Carlos A G Van Mieghem; Filippo Cademartiri; Nico R Mollet; Patrizia Malagutti; Marco Valgimigli; Willem B Meijboom; Francesca Pugliese; Eugene P McFadden; Jurgen M R Ligthart; Giuseppe Runza; Nico Bruining; Pieter C Smits; Evelyn Regar; Willem J van der Giessen; Georgios Sianos; Ron T van Domburg; Peter P T de Jaegere; Gabriel P Krestin; Patrick Washington Serruys; Pim J de Feyter
Multislice spiral computed tomography for the evaluation of stent patency after left main coronary artery stenting: a comparison with conventional coronary angiography and intravascular ultrasound.
Circulation 2006;114(7):645-53.
2006: Giuseppe G L Biondi-Zoccai; Antonio Abbate; Marco Valgimigli; Luca Testa; Pierfrancesco Agostoni
From chaotic to coordinated clinical research: the case of acetylcysteine.
Archives of internal medicine 2006;166(15):1668; author reply 1669.
2006: Gaston A. Rodriguez-Granillo; Héctor M García-García; Marco Valgimigli; Sophia Vaina; Carlos A G Van Mieghem; Robert Jan Van geuns; Martin van der Ent; Evelyn Regar; Peter P T de Jaegere; Willem J van der Giessen; Pim de Feyter; Patrick Washington Serruys
Global characterization of coronary plaque rupture phenotype using three-vessel intravascular ultrasound radiofrequency data analysis.
European heart journal 2006;27(16):1921-7.
2006: Angela Hoye; Ioannis Iakovou; Lei Ge; Carlos A G Van Mieghem; Andrew Ong; John Cosgrave; Giuseppe M Sangiorgi; Flavio Airoldi; Matteo Montorfano; Iassen Michev; Alaide Chieffo; Mauro Carlino; Nicola Corvaja; Jiro Aoki; Gaston A. Rodriguez-Granillo; Marco Valgimigli; Georgios Sianos; Willem J van der Giessen; Pim J de Feyter; Ron T van Domburg; Patrick Washington Serruys; Antonio Colombo
Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome.
Journal of the American College of Cardiology 2006;47(10):1949-58.
2006: Marco Valgimigli; Paul Steendijk; Patrick Washington Serruys; Pascal Vranckx; Frans Boomsma; Emile E M Onderwater; Sophia Vaina; Jurgen M R Ligthart; Eugene McFadden; Martin van der Ent; Peter P T de Jaegere; Georgios Sianos
Use of Impella Recover(R) LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions; clinical, haemodynamic and biochemical findings.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2006;2(1):91-100.
2006: Gaston A. Rodriguez-Granillo; Héctor M García-García; Marco Valgimigli; Johannes A Schaar; Ravindra Pawar; Willem J van der Giessen; Evelyn Regar; Antonius F W van der Steen; Pim J de Feyter; Patrick Washington Serruys
In vivo relationship between compositional and mechanical imaging of coronary arteries. Insights from intravascular ultrasound radiofrequency data analysis.
American heart journal 2006;151(5):1025.e1-6.
2006: Gaston A. Rodriguez-Granillo; Eugene P McFadden; Marco Valgimigli; Carlos A G Van Mieghem; Evelyn Regar; Pim J de Feyter; Patrick Washington Serruys
Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation.
American heart journal 2006;151(5):1020-24.
2006: Marco Valgimigli; Patrizia Malagutti; Gaston A. Rodriguez-Granillo; Hector M. Garcia; Jawed Polad; Keiichi Tsuchida; Evelyn Regar; Willem J van der Giessen; Peter P T de Jaegere; Pim de Feyter; Patrick Washington Serruys
Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registries.
Journal of the American College of Cardiology 2006;47(8):1530-7.
2006: Marco Valgimigli; Patrizia Malagutti; Carlos A G Van Mieghem; Sophia Vaina; Jurgen M R Ligthart; Georgios Sianos; Patrick Washington Serruys
Persistence of neointimal growth 12 months after intervention and occurrence of delayed restenosis in patients with left main coronary artery disease treated with drug-eluting stents.
Journal of the American College of Cardiology 2006;47(7):1491-4.
2006: Carlos A G Van Mieghem; Eugene P McFadden; Pim J de Feyter; Nico Bruining; Johannes A Schaar; Nico R Mollet; Filippo Cademartiri; Dick M Goedhart; Sebastiaan De Winter; Gaston Rodriguez Granillo; Marco Valgimigli; Frits Mastik; Antonius F W van der Steen; Willem J van der Giessen; Georgios Sianos; Bianca Backx; Marie-angèle Morel; Gerrit-Anne van Es; Andrew Zalewski; Patrick Washington Serruys
Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities: the Integrated Biomarker and Imaging Study (IBIS).
Journal of the American College of Cardiology 2006;47(6):1134-42.
2006: Pierfrancesco Agostoni; Marco Valgimigli; Giuseppe G L Biondi-Zoccai; Antonio Abbate; Hector M. Garcia; Maurizio Anselmi; Marco Turri; Eugene P McFadden; Corrado Vassanelli; Patrick Washington Serruys; Antonio Colombo
Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: insights from a systematic overview of randomized trials in light of the drug-eluting stent era.
American heart journal 2006;151(3):682-9.
2006: Paul Steendijk; Pieter C Smits; Marco Valgimigli; Willem J van der Giessen; Emile E M Onderwater; Patrick Washington Serruys
Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure-volume loops.
Nature clinical practice. Cardiovascular medicine 2006;3 Suppl 1():S94-100.
2006: Pierfrancesco Agostoni; Marco Valgimigli; Antonio Abbate; John Cosgrave; Mara Pilati; Giuseppe G L Biondi-Zoccai
Is late luminal loss an accurate predictor of the clinical effectiveness of drug-eluting stents in the coronary arteries?
The American journal of cardiology 2006;97(5):603-5.
2006: Marco Valgimigli; Gaston A. Rodriguez-Granillo; Hector M. Garcia; Patrizia Malagutti; Evelyn Regar; Peter P T de Jaegere; Pim de Feyter; Patrick Washington Serruys
Distance from the ostium as an independent determinant of coronary plaque composition in vivo: an intravascular ultrasound study based radiofrequency data analysis in humans.
European heart journal 2006;27(6):655-63.
2006: Gaston A. Rodriguez-Granillo; Patrick Washington Serruys; Hector M. Garcia; Jiro Aoki; Marco Valgimigli; Carlos A G Van Mieghem; Eugene McFadden; Peter P T de Jaegere; Pim de Feyter
Coronary artery remodelling is related to plaque composition.
Heart (British Cardiac Society) 2006;92(3):388-91.
2006: Gaston A. Rodriguez-Granillo; Héctor M García-García; Jolanda Wentzel; Marco Valgimigli; Keiichi Tsuchida; Wim van der Giessen; Peter P T de Jaegere; Evelyn Regar; Pim J de Feyter; Patrick Washington Serruys
Plaque composition and its relationship with acknowledged shear stress patterns in coronary arteries.
Journal of the American College of Cardiology 2006;47(4):884-5.
2006: Marco Valgimigli; Patrizia Malagutti; Jiro Aoki; Hector M. Garcia; Gaston A. Rodriguez-Granillo; Carlos A G Van Mieghem; Jurgen M R Ligthart; Andrew Ong; Georgios Sianos; Evelyn Regar; Ron T van Domburg; Pim de Feyter; Peter P T de Jaegere; Patrick Washington Serruys
Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis.
Journal of the American College of Cardiology 2006;47(3):507-14.
2006: Pieter C Smits; Christoph Nienaber; Antonio Colombo; Hüseyin Ince; Mauro Carlino; Dominic A M J Theuns; Elena Biagini; Marco Valgimigli; Emile E M Onderwater; Paul Steendijk; Nicholas S Peters; Dick M Goedhart; Patrick Washington Serruys
Myocardial repair by percutaneous cell transplantation of autologous skeletal myoblast as a stand alone procedure in post myocardial infarction chronic heart failure patients.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2006;1(4):417-24.
2006: Keiichi Tsuchida; Héctor M García-García; Andrew Ong; Marco Valgimigli; Jiro Aoki; Tessa Rademaker-Havinga; Marie-angèle Morel; Gerrit-Anne van Es; Nico Bruining; Patrick Washington Serruys
Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trial.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2006;67(2):188-97.
2006: Giuseppe G L Biondi-Zoccai; Marzia Lotrionte; Antonio Abbate; Luca Testa; Enrico Remigi; Francesco Burzotta; Marco Valgimigli; Enrico Romagnoli; Filippo Crea; Pierfrancesco Agostoni
Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study.
BMJ (Clinical research ed.) 2006;332(7535):202-9.
2006: Giuseppe G L Biondi-Zoccai; Antonio Abbate; Pierfrancesco Agostoni; Marco Valgimigli; Giuseppe M Sangiorgi
Drawbacks of nonrandomized trials in acute coronary syndromes.
The American journal of cardiology 2006;97(1):151.
2005: Gaston A. Rodriguez-Granillo; Héctor M García-García; Eugène P Mc Fadden; Marco Valgimigli; Jiro Aoki; Pim de Feyter; Patrick Washington Serruys
In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis.
Journal of the American College of Cardiology 2005;46(11):2038-42.
2005: Marco Valgimigli
Direct comparisons of sirolimus-eluting and paclitaxel-eluting stents are needed. Commentary.
Evidence-based cardiovascular medicine 2005;9(4):294-6.
2005: Marco Valgimigli; Paolo A M Squasi; Stavroula Gaitani; Chiara Arcozzi; Stefania Martano; Roberto Ferrari
[Markers of coronary damage. From diagnosis to prognosis].
Recenti progressi in medicina 2005;96(11):566-72.
2005: Jiro Aoki; Andrew Ong; Gaston A. Rodriguez-Granillo; Eugene P McFadden; Carlos A G Van Mieghem; Marco Valgimigli; Keiichi Tsuchida; Georgios Sianos; Evelyn Regar; Peter P T de Jaegere; Willem J van der Giessen; Pim J de Feyter; Ron T van Domburg; Patrick Washington Serruys
"Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions.
American heart journal 2005;150(5):994-9.
2005: Pierluigi Tricoci; Robert A Harrington; Marco Valgimigli
Letter regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study".
Circulation 2005;112(17):e282; author reply e283.
2005: Marco Valgimigli; Pierfrancesco Agostoni; Giuseppe G L Biondi-Zoccai
Complete myocardial revascularization: between myth and reality.
European heart journal 2005;26(17):1809-10; author reply 1810-1.
2005: Sjoerd H Hofma; Andrew Ong; Jiro Aoki; Carlos A G Van Mieghem; Gaston A. Rodriguez-Granillo; Marco Valgimigli; Evelyn Regar; Peter P T de Jaegere; Eugene P McFadden; Georgios Sianos; Willem J van der Giessen; Pim J de Feyter; Ron T van Domburg; Patrick Washington Serruys
One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents.
Heart (British Cardiac Society) 2005;91(9):1176-80.
2005: Marco Valgimigli; Gian Matteo Rigolin; Corrado Cittanti; Patrizia Malagutti; Salvatore Curello; Gianfranco Percoco; Anna Maria Bugli; Matteo Della Porta; Letizia Zenone Bragotti; Lucia Ansani; Endri Mauro; Arnalda Lanfranchi; Melchiore Giganti; Luciano Feggi; Gianluigi Castoldi; Roberto Ferrari
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile.
European heart journal 2005;26(18):1838-45.
2005: Angela Hoye; Andrew Ong; Jiro Aoki; Carlos A G Van Mieghem; Gaston A. Rodriguez-Granillo; Marco Valgimigli; Georgios Sianos; Eugene McFadden; Willem J van der Giessen; Pim J de Feyter; Ron T van Domburg; Patrick Washington Serruys
Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stent.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2005;1(2):193-7.
2005: Patrizia Malagutti; Marco Valgimigli; P J de Feyter
EuroPCR highlights 2005.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2005;1(2):139-44.
2005: Héctor M García-García; Marco Valgimigli; Chaim Lotan
Beyond crossing a chronic total occlusionAre the drug-eluting stents the solution for this old problem?
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2005;1(2):129-31.
2005: Gaston A. Rodriguez-Granillo; Marco Valgimigli; Hector M. Garcia; Andrew Ong; Jiro Aoki; Carlos A G Van Mieghem; Keiichi Tsuchida; Georgios Sianos; Eugene McFadden; Willem J van der Giessen; Ron T van Domburg; Pim de Feyter; Patrick Washington Serruys
One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries.
The Journal of invasive cardiology 2005;17(8):409-12.
2005: Keiichi Tsuchida; Andrew Ong; Jiro Aoki; Carlos A G Van Mieghem; Gaston A. Rodriguez-Granillo; Marco Valgimigli; Georgios Sianos; Evelyn Regar; Eugene P McFadden; Willem J van der Giessen; Pim J de Feyter; Peter P T de Jaegere; Ron T van Domburg; Patrick Washington Serruys
Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents.
The American journal of cardiology 2005;96(3):395-8.
2005: Andrew Ong; Jiro Aoki; Carlos A G Van Mieghem; Gaston A. Rodriguez-Granillo; Marco Valgimigli; Keiichi Tsuchida; Karel Sonnenschein; Evelyn Regar; Willem J van der Giessen; Peter P T de Jaegere; Georgios Sianos; Eugene P McFadden; Pim J de Feyter; Ron T van Domburg; Patrick Washington Serruys
Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries).
The American journal of cardiology 2005;96(3):358-62.
2005: Carlos A G Van Mieghem; Nico Bruining; Johannes A Schaar; Eugene McFadden; Nico R Mollet; Filippo Cademartiri; Frits Mastik; Jurgen M R Ligthart; Gaston A Rodriguez Granillo; Marco Valgimigli; Georgios Sianos; Willem J van der Giessen; Bianca Backx; Marie-angèle Morel; Gerrit-Anne van Es; Jonathon D Sawyer; June Kaplow; Andrew Zalewski; Antonius F W van der Steen; Pim de Feyter; Patrick Washington Serruys
Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology.
The international journal of cardiovascular imaging 2005;21(4):425-41.
2005: Marco Valgimigli; Paul Steendijk; Georgios Sianos; Emile E M Onderwater; Patrick Washington Serruys
Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous Impella Recover LP 2.5 assist device during high-risk coronary intervention.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2005;65(2):263-7.
2005: Marco Valgimigli; Gianfranco Percoco; Patrizia Malagutti; Gianluca Campo; Fabrizio Ferrari; Dario Barbieri; Giordano Cicchitelli; Eugene P McFadden; Fabia Merlini; Lucia Ansani; Gabriele Guardigli; Alessandro Bettini; Giovanni Parrinello; Eric Boersma; Roberto Ferrari
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial.
JAMA : the journal of the American Medical Association 2005;293(17):2109-17.
2005: Angela Hoye; Carlos A G Van Mieghem; Andrew Ong; Jiro Aoki; Gaston A. Rodriguez-Granillo; Marco Valgimigli; Keiichi Tsuchida; Georgios Sianos; Eugene McFadden; Willem J van der Giessen; Pim J de Feyter; Ron T van Domburg; Patrick Washington Serruys
Treatment of de novo bifurcation lesions: comparison of Sirolimus- and Paclitaxel-eluting stents.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2005;1(1):24-30.
2005: Andrew Ong; Patrick Washington Serruys; Jiro Aoki; Angela Hoye; Carlos A G Van Mieghem; Gaston A. Rodriguez-Granillo; Marco Valgimigli; Karel Sonnenschein; Evelyn Regar; Martin van der Ent; Peter P T de Jaegere; Eugene P McFadden; Georgios Sianos; Willem J van der Giessen; Pim J de Feyter; Ron T van Domburg
The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry.
Journal of the American College of Cardiology 2005;45(7):1135-41.
2005: Marco Valgimigli; Carlos A G Van Mieghem; Andrew Ong; Jiro Aoki; Gaston A Rodriguez Granillo; Eugene P McFadden; Arie Pieter Kappetein; Pim J de Feyter; Pieter C Smits; Evelyn Regar; Willem J van der Giessen; Georgios Sianos; Peter P T de Jaegere; Ron T van Domburg; Patrick Washington Serruys
Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH).
Circulation 2005;111(11):1383-9.
2005: Pierfrancesco Agostoni; Marco Valgimigli; Carlos A G Van Mieghem; Gaston A. Rodriguez-Granillo; Jiro Aoki; Andrew Ong; Keiichi Tsuchida; Eugene P McFadden; Jurgen M R Ligthart; Pieter C Smits; Peter P T de Jaegere; Georgios Sianos; Willem J van der Giessen; Pim de Feyter; Patrick Washington Serruys
Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance.
The American journal of cardiology 2005;95(5):644-7.
2005: Marco Valgimigli; Claudio Ceconi; Patrizia Malagutti; Elisa Merli; Olga Soukhomovskaia; Gloria Francolini; Giordano Cicchitelli; Adriana Olivares; Giovanni Parrinello; Gianfranco Percoco; Gabriele Guardigli; Donato Mele; Roberto Pirani; Roberto Ferrari
Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study.
Circulation 2005;111(7):863-70.
2005: Chiara Pedone; Maniyal Vijayakumar; Jourgen M L Ligthart; Marco Valgimigli; Elena Biagini; Nico De Jong; Patrick Washington Serruys; Folkert J Ten Cate
Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy.
International journal of cardiovascular interventions 2005;7(3):134-7.
2005: Gaston A. Rodriguez-Granillo; Marco Valgimigli; Andrew Ong; Jiro Aoki; Carlos A G Van Mieghem; Angela Hoye; Keiichi Tsuchida; Eugene McFadden; Pim de Feyter; Patrick Washington Serruys
Paclitaxel eluting stents for the treatment of angiographically non-significant atherosclerotic lesions.
International journal of cardiovascular interventions 2005;7(2):68-71.
2005: Gaston A. Rodriguez-Granillo; Jiro Aoki; Andrew Ong; Marco Valgimigli; Carlos A G Van Mieghem; Evelyn Regar; Eugene McFadden; Pim de Feyter; Patrick Washington Serruys
Methodological considerations and approach to cross-technique comparisons using in vivo coronary plaque characterization based on intravascular ultrasound radiofrequency data analysis: insights from the Integrated Biomarker and Imaging Study (IBIS).
International journal of cardiovascular interventions 2005;7(1):52-8.
2005: Angela Hoye; Carlos A G Van Mieghem; Andrew Ong; Jiro Aoki; Gaston A. Rodriguez-Granillo; Marco Valgimigli; Keiichi Tsuchida; Georgios Sianos; Eugene P McFadden; Willem J van der Giessen; Pim J de Feyter; Ron T van Domburg; Patrick Washington Serruys
Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited.
International journal of cardiovascular interventions 2005;7(1):36-40.
2004: Marco Valgimigli; Gian Matteo Rigolin; Alessandro Fucili; Matteo Della Porta; Olga Soukhomovskaia; Patrizia Malagutti; Anna Maria Bugli; Letizia Zenone Bragotti; Gloria Francolini; Endri Mauro; Gianluigi Castoldi; Roberto Ferrari
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure.
Circulation 2004;110(10):1209-12.
2004: Marco Valgimigli; Gianfranco Percoco; Dario Barbieri; Fabrizio Ferrari; Gabriele Guardigli; Giovanni Parrinello; Olga Soukhomovskaia; Roberto Ferrari
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial.
Journal of the American College of Cardiology 2004;44(1):14-9.
2004: Marco Valgimigli; Elisa Merli; Patrizia Malagutti; Olga Soukhomovskaia; Giordano Cicchitelli; Alessandra Antelli; Donatella Canistro; Gloria Francolini; Gaetano Macrì; Francesca Mastrorilli; Moreno Paolini; Roberto Ferrari
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction.
Journal of the American College of Cardiology 2004;43(11):2000-8.
2004: Marco Valgimigli; Gianfranco Percoco; Giordano Cicchitelli; Fabrizio Ferrari; Dario Barbieri; Lucia Ansani; Gabriele Guardigli; Giovanni Parrinello; Patrizia Malagutti; Olga Soukhomovskaia; Alessandro Bettini; Gianluca Campo; Roberto Ferrari
High-dose bolus tirofiban and sirolimus eluting stent versus abiciximab and bare metal stent in acute myocardial infarction (STRATEGY) study--protocol design and demography of the first 100 patients.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(3):225-30.
2003: Marco Valgimigli; Elisa Merli; Patrizia Malagutti; Olga Soukhomovskaia; Giordano Cicchitelli; Gaetano Macrì; Roberto Ferrari
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress.
Archives of biochemistry and biophysics 2003;420(2):255-61.
2003: Marco Valgimigli; Laura Agnoletti; Salvatore Curello; Laura Comini; Gloria Francolini; Francesca Mastrorilli; Elisa Merli; Roberto Pirani; Gabriele Guardigli; Piergiovanni Grigolato; Roberto Ferrari
Serum from patients with acute coronary syndromes displays a proapoptotic effect on human endothelial cells: a possible link to pan-coronary syndromes.
Circulation 2003;107(2):264-70.
2002: Marco Valgimigli; Luca Valgimigli; Davide Trerè; Stefano Gaiani; Gian Franco Pedulli; Laura Gramantieri; Luigi Bolondi
Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation.
Free radical research 2002;36(9):939-48.
2002: Marco Valgimigli; Roberto Ferrari; Serge Masson; Roberto Latini
[Refractory heart failure. Antagonism of tumor necrosis factor alpha and endothelin in humans: 2 promises still to be honored].
Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 2002;3(8):793-803.
2001: Marco Valgimigli; Salvatore Curello; Claudio Ceconi; Laura Agnoletti; Laura Comini; Tiziana Bachetti; Elisa Merli; Roberto Ferrari
Neurohormones, cytokines and programmed cell death in heart failure: a new paradigm for the remodeling heart.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2001;15(6):529-37.
2001: Angelo Placci; G Melandri; Laura Cecilioni; Marco Valgimigli; Luigi Bolondi; Angelo Branzi
[Late-appearing cholestatic icterus after a month of treatment with ticlopidine].
Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 2001;2(11):1240-2.
2001: Maria Giulia Battelli; Silvia Musiani; Marco Valgimigli; Laura Gramantieri; F Tomassoni; Luigi Bolondi; Fiorenzo Stirpe
Serum xanthine oxidase in human liver disease.
The American journal of gastroenterology 2001;96(4):1194-9.
2000: Luca Valgimigli; Marco Valgimigli; Stefano Gaiani; Gian Franco Pedulli; Luigi Bolondi
Measurement of oxidative stress in human liver by EPR spin-probe technique.
Free radical research 2000;33(2):167-78.
2000: Fabio Piscaglia; Marco Valgimigli; Claudio Rapezzi; Marinella Ferlito; Stefano Gaiani; Sebastiano Siringo; Laura Gramantieri; Luigi Bolondi
Left ventricular volumes in liver cirrhosis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2000;32(5):392-7.
2000: Fabio Piscaglia; Sebastiano Siringo; R C Hermida; Cristina Legnani; Marco Valgimigli; Gabriele Donati; G Palareti; Laura Gramantieri; Stefano Gaiani; A K Burroughs; Luigi Bolondi
Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices.
Hepatology (Baltimore, Md.) 2000;31(2):349-57.
1999: Laura Gramantieri; Pasquale Chieco; M Di Tomaso; L Masi; Fabio Piscaglia; Stefano Brillanti; Stefano Gaiani; Marco Valgimigli; Alighieri Mazziotti; Luigi Bolondi
Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3468-75.
1999: Fabio Piscaglia; Gianni Zironi; Stefano Gaiani; Alighieri Mazziotti; Antonino Cavallari; Laura Gramantieri; Marco Valgimigli; Luigi Bolondi
Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study.
Hepatology (Baltimore, Md.) 1999;30(1):58-64.
1999: Marco Valgimigli; Fabio Piscaglia; Stefano Gaiani; Luigi Bolondi
Splanchnic arterial Doppler parameters in portal hypertension.
Hepatology (Baltimore, Md.) 1999;29(5):1610.
1998: Fabio Piscaglia; Marco Valgimigli; Carla Serra; Gabriele Donati; Laura Gramantieri; Luigi Bolondi
Duplex Doppler findings in splenic arteriovenous fistula.
Journal of clinical ultrasound : JCU 1998;26(2):103-5.